Biocodex Microbiota Institute

What Biocodex Microbiota Institute does

The Biocodex Microbiota Institute is a free, non-commercial scientific communication platform owned by the French pharmaceutical company Biocodex (a SAS headquartered in Gentilly, France, with €4,284,000 share capital). Its function is to publish and disseminate educational content on the human microbiota and related disorders — covering gut, vaginal, oral, skin, and lung microbiota — for two distinct audiences: healthcare professionals and the general public. Content formats include expert interviews, podcasts, videos, articles, and the recurring International Microbiota Observatory consumer survey, which produces annual cross-country data on microbiota awareness and behaviors.

The platform is delivered through a multilingual website (seven languages) and an active social media presence spanning Bluesky, Instagram, Facebook, X, LinkedIn, and YouTube, with a newsletter community as a recurring touchpoint. Distribution to clinicians is reinforced through CME-accredited training delivered via a partnership with Xpeer Medical Education, and accessibility is supported through a partnership with AccessiWay for AI-based digital accessibility tooling (formalized September 22, 2023). The editorial remit extends across women's health, mental health, oncology, nutrition, obesity, diabetes, and physical exercise, in addition to core microbiota topics.

The business model is not transactional: the Institute generates no direct revenue. It operates as a corporate scientific communication function — effectively a cost center — funded by parent Biocodex to support scientific authority, brand presence, and stakeholder engagement around microbiota. There are no subscription fees, advertising placements, or paid product lines disclosed.

Name

Biocodex Microbiota Institute

Legal name

BIOCODEX

Website

https://biocodexmicrobiotainstitute.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

The Biocodex Microbiota Institute is a free, multilingual (seven-language) scientific communication platform that publishes educational content on the human microbiota for healthcare professionals and the general public, funded by parent Biocodex as a non-commercial corporate function.

Ownership category

akta.pro rank

Product category

Medical Education Content

NAICS

Other Scientific and Technical Consulting Services (54169), All Other Schools and Instruction (61169)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Microbiome Diagnostics & Biomarker Platforms (gut/skin/oral/vaginal) (HLAAAFAH)

akta.pro secondary industries

Microbiome & Metagenomics Services (HLAGANAH), Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)

Keywords

• Microbiota education content
• Health science communication
• Medical education resources
• Microbiome research publishing
• Gut health information

Headquarters

HQ city

Gentilly

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Institutional/Sponsor Funding: The Biocodex Microbiota Institute operates as a scientific communication initiative funded by Biocodex, a pharmaceutical company specializing in microbiota products. The institute provides free educational content to healthcare professionals and the general public, functioning as a corporate scientific communication platform rather than a revenue-generating entity.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Biocodex Microbiota Institute operates as a free, multilingual educational content platform that publishes scientific information about human microbiota (gut, skin, vaginal, ENT, pulmonary, urinary) and related disorders. It serves two distinct audiences — healthcare professionals (with a dedicated portal offering CME courses, congress reviews, and expert analyses) and the general public (with accessible articles, Q&A, and patient stories). The institute is funded and operated by its parent pharmaceutical company, Biocodex, as a corporate scientific communication initiative and does not sell products or charge for content.

Product overview

Biocodex Microbiota Institute operates as a dual-audience educational platform providing scientific information about microbiota and human health. The core offering is the Institute's website, which serves both the general public and healthcare professionals through segregated sections. For the lay public, the Institute offers publications including news articles, thematic folders, Q&A sections, patient stories, and expert viewpoints. For healthcare professionals (HCPs), a dedicated portal provides congress information, CME courses, diagnosis tools, and specialized publications. The Institute also conducts the annual International Microbiota Observatory, a research initiative publishing survey results on public awareness of microbiota topics. Content is distributed through newsletter subscriptions (The Essential for general public, Microbiota Digest for HCPs) and the Microbiotalks program featuring short scientific conferences.

Differentiator

Problem solved

Functional benefit

Products and services

• Microbiota Publications Library of free scientific publications including news articles, thematic folders, thematic pages, Q&A sections, patient stories, and expert opinions covering microbiota across body systems and related health conditions.

Quantifiable outcome

• Website available in 7+ languages with content covering 9 body microbiota types and 9 disorder categories

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• ZOE: Consumer health platform combining gut microbiome testing with extensive educational content about personalized nutrition and gut health. Comparable in producing consumer-facing educational content about microbiota science, though ZOE pairs content with a paid testing product.
• Seed Health: Microbiome-focused consumer health company producing probiotics and publishing educational content about the microbiome for both consumers and clinicians. Comparable in subject matter focus and educational content-led positioning, though Seed is a commercial DTC brand rather than a non-commercial institute.
• Viome: Direct-to-consumer gut microbiome testing company with substantial educational content about microbiome science, health conditions, and personalized recommendations. Comparable in microbiome subject matter and educational content emphasis, though monetized through testing services.

Direct peers

• Yakult Honsha: Japanese pharmaceutical company specializing in probiotic (Lactobacillus casei Shirota) products with a long-standing corporate scientific communication platform educating healthcare professionals and consumers about gut microbiota. Highly comparable to Biocodex Microbiota Institute in audience structure, content-led model, and pharma-company backing.
• Gut Microbiota for Health (GMFH): Initiative by ESPGHAN-affiliated experts providing scientific information about gut microbiota to healthcare professionals and the general public. Closely comparable in audience (HCPs and consumers), subject matter (gut microbiota), and content-led educational model.
• International Scientific Association for Probiotics and Prebiotics (ISAPP): Non-profit scientific organization that publishes evidence-based information about probiotics, prebiotics, and the microbiome for healthcare professionals, researchers, and consumers. Highly comparable as a content-led, education-focused organization dedicated to disseminating microbiota science to similar audiences.

Broad incumbents

• American Gastroenterological Association (AGA): Major US medical society providing patient and professional education on digestive health topics, including dedicated gut microbiome resources. Comparable as a trusted HCP-facing educational channel on gastrointestinal topics including microbiota, though operating across the full GI disease spectrum.
• Danone (Nutricia Research): Global food and nutrition major with significant microbiome science investments and educational initiatives around probiotics, gut health, and infant nutrition. Comparable as a corporate-backed educational platform targeting HCPs and consumers, though operating across a broader nutritional portfolio.
• Nestlé Health Science: Global nutrition company's health science division with active microbiome research and HCP education programs around gut-brain axis, pediatric nutrition, and metabolic health. Comparable in providing corporate-sponsored scientific content to HCPs, though as part of a much larger healthcare portfolio.

Regional players

• Winclove Probiotics: European probiotic manufacturer with educational content about microbiota science and probiotic applications targeted at healthcare professionals. Comparable in pharma-company-backed educational content model, though primarily European-focused and tied to Winclove's commercial probiotic line.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/Microbiota_Inst
• YouTubeyoutube.com/channel/UCUMoNdF5oh_ruYxpd6tkHoA
• Facebookfacebook.com/MicrobiotaInstitute
• LinkedInlinkedin.com/company/biocodex-microbiota-institute
• Instagraminstagram.com/myhealthmymicrobiota

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biocodex Microbiota Institute